Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
European Journal of Clinical Investigation
|
July 1, 1997
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia
S A Karabina, M Elisaf, E Bairaktari, et al.
European Journal of Clinical Investigation
|
February 26, 2000
Potential aetiological factors concerning the development of osteonecrosis of the femoral head
C Zalavras, Z Dailiana, M Elisaf, et al.
Clinical Biochemistry
|
September 10, 1999
Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patients
E Bairaktari, M Elisaf, A Katsaraki, et al.
Clinical Biochemistry
|
December 22, 2000
Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels
E Bairaktari, K Hatzidimou, C Tzallas, et al.
European Journal of Clinical Investigation
|
December 1, 1996
Lipid profile in patients with microvascular angina
A D Tselepis, M Elisaf, J Goudevenos, et al.
Platelets
|
June 28, 2006
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia
M Elisaf, S A Karabina, E Bairaktari, et al.
Anticancer Research
|
September 1, 1996
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property
M Elisaf, E Bairaktari, C Nicolaides, et al.
Clinical Biochemistry
|
February 19, 2002
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1)
E Bairaktari, M Elisaf, C Tzallas, et al.
International Journal of Clinical Practice
|
October 15, 2011
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance
E Moutzouri, E Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy
|
October 22, 2008
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study
M Florentin, E N Liberopoulos, T D Filippatos, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
European Journal of Clinical Investigation
|
July 1, 1997
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia
S A Karabina, M Elisaf, E Bairaktari, et al.
European Journal of Clinical Investigation
|
February 26, 2000
Potential aetiological factors concerning the development of osteonecrosis of the femoral head
C Zalavras, Z Dailiana, M Elisaf, et al.
Clinical Biochemistry
|
September 10, 1999
Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patients
E Bairaktari, M Elisaf, A Katsaraki, et al.
Clinical Biochemistry
|
December 22, 2000
Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels
E Bairaktari, K Hatzidimou, C Tzallas, et al.
European Journal of Clinical Investigation
|
December 1, 1996
Lipid profile in patients with microvascular angina
A D Tselepis, M Elisaf, J Goudevenos, et al.
Platelets
|
June 28, 2006
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia
M Elisaf, S A Karabina, E Bairaktari, et al.
Anticancer Research
|
September 1, 1996
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property
M Elisaf, E Bairaktari, C Nicolaides, et al.
Clinical Biochemistry
|
February 19, 2002
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1)
E Bairaktari, M Elisaf, C Tzallas, et al.
International Journal of Clinical Practice
|
October 15, 2011
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance
E Moutzouri, E Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy
|
October 22, 2008
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study
M Florentin, E N Liberopoulos, T D Filippatos, et al.
Page
of 16